WO2004096740A2 - Process for preparation of (+)-p-mentha-2,8-diene-1-ol - Google Patents

Process for preparation of (+)-p-mentha-2,8-diene-1-ol Download PDF

Info

Publication number
WO2004096740A2
WO2004096740A2 PCT/US2004/011509 US2004011509W WO2004096740A2 WO 2004096740 A2 WO2004096740 A2 WO 2004096740A2 US 2004011509 W US2004011509 W US 2004011509W WO 2004096740 A2 WO2004096740 A2 WO 2004096740A2
Authority
WO
WIPO (PCT)
Prior art keywords
formula
alkyl
amine
process according
lewis acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2004/011509
Other languages
English (en)
French (fr)
Other versions
WO2004096740A3 (en
Inventor
Hong Gu
J. Kendall Killgore
John R. Duchek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mallinckrodt Inc
Original Assignee
Mallinckrodt Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Inc filed Critical Mallinckrodt Inc
Priority to MXPA05011292A priority Critical patent/MXPA05011292A/es
Priority to EP04760258A priority patent/EP1660421A2/en
Priority to CA2523419A priority patent/CA2523419C/en
Priority to JP2006510032A priority patent/JP2006524247A/ja
Priority to AU2004234350A priority patent/AU2004234350A1/en
Priority to US10/549,976 priority patent/US7323607B2/en
Publication of WO2004096740A2 publication Critical patent/WO2004096740A2/en
Publication of WO2004096740A3 publication Critical patent/WO2004096740A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/04Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reaction of ammonia or amines with olefin oxides or halohydrins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C291/00Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00
    • C07C291/02Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00 containing nitrogen-oxide bonds
    • C07C291/04Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00 containing nitrogen-oxide bonds containing amino-oxide bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Definitions

  • the present relation relates to a process for regio- and stereoselective opening of an epoxide ring, and more particularly to the regio- and stereoselective conversion of (+)- limonene oxide to (+)-p-mentha-2,8-diene-l-ol.
  • Epoxides also known as oxiranes, are useful intermediates in synthesizing active pharmaceutical ingredients and drugs.
  • the inherent polarity and strain of the three- membered ring makes them susceptible to reaction with a large number of reagents.
  • Of particular interest is the stereoselective nucleophilic attack of the epoxide ring to form
  • THC Tetrahydrocannabinol
  • Pha ⁇ naceutical interest in THC has increased due to FDA approval for several therapeutic applications.
  • Many of the known processes for the preparation of THC utilize (+)-p-mentha-2,8-diene-l-ol or an analog thereof as an intermediate.
  • the (+)-p-mentha- 2,8-diene-l-ol or an analog can be prepared from limonene through a synthesis that includes opening an epoxy ring.
  • Conventional methods for converting limonene into (+)- p-mentha-2,8-diene-l-ol include oxidizing limonene with singlet oxygen and conversion using an enzymatic reaction.
  • An aspect of the present invention is to provide a process for the regio- and stereoselective opening of an epoxide ring, the process comprising reacting a compound having the epoxide ring with at least one amine in the presence of at least one Lewis acid.
  • Another aspect of the present invention is to provide a process for preparing (+)-p- mentha-2,8-diene-l-ol and analogs thereof.
  • the process comprises reacting (+)-limonene oxide with an amine in the presence of a Lewis acid to form amine adduct intermediates.
  • the desired amine adduct intermediate is formed at a ratio of .greater than 20: 1 over other reaction products.
  • the desired amine adduct is then oxidized to form an N-oxide that is pyrolized to form (+)-p-mentha-2,8-diene-l-ol.
  • the amine adduct is converted to an acid salt and then base hydrolyzed to form (+)-p-mentha-2,8-diene-l-ol.
  • epoxide ring where one carbon of the epoxide ring is more substituted.
  • a compound having such an epoxide ring is reacted with an amine in the presence of a Lewis acid.
  • nucleophilic attack This allows for the regio- and stereoselective opening of the epoxide ring.
  • step a (major) (minor)
  • step b step c
  • R 4 is an alkyl, alkenyl or alcohol.
  • step a (major) (minor)
  • Reaction step (a) comprises reacting a mixture of cis and trans isomers of (+)-
  • the amine may be primary, wherein R 2 and R 3 are H; secondary, wherein R
  • R ls R 2 and R 3 in the tertiary amine are limited only in that R lt R 2 and R 3 must
  • Suitable amines include, but are not limited to, amines wherein R 1; R and R 3 are
  • lower alkyl radicals having from about 1 to about 6 carbons, or aryl groups.
  • the Lewis acid may be any compound containing an element that is two electrons
  • acids include but are not limited to non-protic acids including metals, primarily halides,
  • alkyls and ether complexes thereof.
  • Suitable alkyl metal halides include MRX wherein
  • R is an alkyl, preferably having 1 to 6 carbons.
  • M is a metal, including but not limited to
  • Suitable ether complexes include those of the formula MOR, wherein M is a metal and R is an alkyl, preferably having 1 to 6 carbons. While
  • the metal is typically selected from Group I alkali metals, any suitable metal may be any suitable metal.
  • M is selected from Li, K and Na,
  • R is selected from methyl, ethyl, propyl or butyl.
  • reaction products of step (a) are the amine adducts Formula (2b) and Formula
  • Step (a) leads to a significant improvement of the regio- and stereoselectivity of the
  • (+)-limonene oxide reaction of (+)-limonene oxide with the primary or secondary amine. Only one major
  • Formula (2b) is formed at a ratio of
  • Another advantage of the present invention is that the (+)-trans-limonene oxide
  • Suitable acids include but are not limited to HCl salt using concentrated hydrochloric acid
  • step (b) the amine adduct of Formula (2b) is oxidized to form the N-oxide of
  • a peracid for example about 30% to about 50% hydrogen peroxide (H 2 O ) in the
  • Suitable alcohols include but are not limited to alkyl
  • step (c) the N-oxide intermediate Formula (4b) is pyrolized to produce (+)-p- mentha-2,8-diene-l-ol.
  • This pyrolysis reaction to eliminate the tertiary amine oxide is known as a Cope elimination.
  • the pyrolysis takes place in a
  • solvent system including toluene at a temperature of at least about 110° C, or at any
  • the pyrolysis takes place in toluene in the presence of at least one particulate matter such as zeolites or silica gels.
  • the particulate matter is SiO 2 or molecular sieves.
  • the overall yield of the conversion of (+)-limonene oxide to (+)-p-mentha-2,8- diene-1-ol of the present invention is typically about 50%.
  • R t and R 2 are H, alkyl or aryl
  • R5 is an H, aryl or alkyl; wherein R 4 is an alkyl, alkenyl or alcohol; and wherein X is a halide.
  • the amine adduct of Formula (2b) reacts with the R 5 X to form the quaternary salt of Formula (6b) that is then heated under basic condition to form (+)-p-mentha-2,8-diene- l-ol of Formula (5b).
  • Mel is used, as illustrated below.
  • (+)-limonene oxide 40.00 g (0.26 mol) was dissolved into 90 ml of ethanol and placed into a 250 ml 3 neck round bottom flask.
  • the ethanol was distilled off from the reaction mixture under vacuum to give a light yellow oil.
  • the oil was then re-dissolved into 200 ml of chloroform, and the resulting solution was washed with 100 ml of deionized water twice and 100 ml of brine once, and finally dried with anhydrous MgSO 4 .
  • the solid was filtered out and the solvent removed under vacuum to give a light yellow oil.
  • the reaction product was analyzed by HPLC and compared to an authentic sample. The results indicated that the reaction product contained the major product II and a minor amount of m.
  • Example 2 substituting lithium bromide in place of the lithium acetate in the reaction.
  • reaction mixture was continuously stirred at 50° C for about 16 hours.
  • (lS,2S,4R)-2-(N-diisopropyl)-l-methyl-4-(l-methylethenyl)-cyclohexanol was synthesized as described in example 5, by utilizing diisopropylamine as the amine.
  • the product, (lS,2S,4R)-2-(N-diisopropyl)-l-methyl-4-(lmethylethenyl)- cyclohexanol was further purified and isolated by recrystallization in isopropanol.
  • reaction mixture was heated to reflux for about 6 hours and followed by HPLC. Upon completion of the reaction the reaction mixture was filtered and the solvent
  • the above compound was recovered as a colorless oil by fractional distillation.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PCT/US2004/011509 2003-04-24 2004-04-14 Process for preparation of (+)-p-mentha-2,8-diene-1-ol Ceased WO2004096740A2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
MXPA05011292A MXPA05011292A (es) 2003-04-24 2004-04-14 Proceso para la preparacion de (+)-p-menta-2,8-dien-1-ol.
EP04760258A EP1660421A2 (en) 2003-04-24 2004-04-14 Process for preparation of (+)-p-mentha-2,8-diene-1-ol
CA2523419A CA2523419C (en) 2003-04-24 2004-04-14 Process for preparation of (+)-p-mentha-2,8-diene-1-ol
JP2006510032A JP2006524247A (ja) 2003-04-24 2004-04-14 (+)−p−メンタ−2,8−ジエン−1−オールの製造方法
AU2004234350A AU2004234350A1 (en) 2003-04-24 2004-04-14 Process for preparation of (+)-p-mentha-2,8-diene-1-ol
US10/549,976 US7323607B2 (en) 2003-04-24 2004-04-14 Process for preparation of (+)-p-mentha-2,8-diene-1-ol

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46504603P 2003-04-24 2003-04-24
US60/465,046 2003-04-24

Publications (2)

Publication Number Publication Date
WO2004096740A2 true WO2004096740A2 (en) 2004-11-11
WO2004096740A3 WO2004096740A3 (en) 2005-06-02

Family

ID=33418173

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/011509 Ceased WO2004096740A2 (en) 2003-04-24 2004-04-14 Process for preparation of (+)-p-mentha-2,8-diene-1-ol

Country Status (8)

Country Link
US (1) US7323607B2 (enExample)
EP (1) EP1660421A2 (enExample)
JP (1) JP2006524247A (enExample)
CN (1) CN1777569A (enExample)
AU (1) AU2004234350A1 (enExample)
CA (1) CA2523419C (enExample)
MX (1) MXPA05011292A (enExample)
WO (1) WO2004096740A2 (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2123264A1 (en) 2006-04-24 2009-11-25 Allergan, Inc. Heterocyclic derivatives as abnormal cannabidiols agents for lowering intraocular pressure
CN112661656A (zh) * 2020-12-19 2021-04-16 浙江新和成股份有限公司 (1s,4r)-1-甲基-4-(1-甲基乙烯基)-2-环己烯-1-醇的制备方法
EP4144717A1 (en) * 2021-09-07 2023-03-08 SCI Pharmtech Inc Method for purification of terpenoid amino alcohol derivatives

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3538164A (en) * 1968-02-08 1970-11-03 Reynolds Tobacco Co R Synthesis of dihydrocarvone
US3814733A (en) * 1970-07-27 1974-06-04 Smc Corp Isomerization of(+)-trans-2,3-epoxy-ciscarane to(+)-cis-2,8-p-methadiene-1-ol
US3734930A (en) * 1971-09-22 1973-05-22 R Razdan Direct synthesis of ({31 )-trans-{66 {11 tetrahydrocannabinol from olivetol and ({30 )-trans-{66 {11 -carene oxide
US4025516A (en) * 1975-06-23 1977-05-24 The John C. Sheehan Institute For Research, Inc. Process for the preparation of (-)-6a,10a-trans-6a,7,8,10a-tetrahydrodibenzo[b,d]-pyrans
IL48824A (en) * 1976-01-12 1980-05-30 Yissum Res Dev Co Pharmaceutical compositions containing (3s,js) tetrahydrocanabinol derivatives and some novel compounds of this type
US4296257A (en) * 1980-01-07 1981-10-20 Scm Corporation Process for producing dihydrocarvone geometric isomers
CH646933A5 (fr) * 1981-05-04 1984-12-28 Firmenich & Cie Procede pour la preparation de (+)-p-mentha-2,8-diene-1-ol.
US6262278B1 (en) * 1995-03-14 2001-07-17 President And Fellows Of Harvard College Stereoselective ring opening reactions
US5777137A (en) * 1995-11-01 1998-07-07 University Of Florida Pancratistatins and processes for their production

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
ASAO N ET AL: "sigma-pi Chelation-controlled chemoselective ring openings of epoxides" TETRAHEDRON LETTERS, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 42, no. 44, 29 October 2001 (2001-10-29), pages 7903-7905, XP004308032 ISSN: 0040-4039 *
DATABASE BEILSTEIN [Online] BEILSTEIN INSTITUTE FOR ORGANIC CHEMISTRY, FRANKFURT-MAIN, DE; XP002297890 retrieved from XFIRE accession no. RID1459337 & EGUCHI, Y.; SASAKI, F.; TAKASHIMA, Y. ET AL.: CHEM. PHARM. BULL., vol. 39, no. 3, 1991, pages 795-797, *
DATABASE BEILSTEIN [Online] BEILSTEIN INSTITUTE FOR ORGANIC CHEMISTRY, FRANKFURT-MAIN, DE; XP002297891 retrieved from XFIRE accession no. RID1454331 & GALVEZ, C. AND VILADOMS, P.: HETEROCYCL. CHEM., vol. 21, 1984, pages 421-423, *
HUDRLIK, P.; HUDRLIK, A.; KULKARNI, A.: "Stereospecific synthesis of enamines from alpha,beta-epoxysilanes" TETRAHEDRON LETT., vol. 26, no. 2, 1985, XP002297753 *
NAKAI K ET AL: "A One-pot Aza-Payne Rearrangement-Epoxide Ring Opening Reaction of 2-Aziridinemethanols: A Regio- and Stereoselective Synthetic Route to Diastereomerically Pure 1,2-Amino Alcohols" TETRAHEDRON LETTERS, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 36, no. 35, 28 August 1995 (1995-08-28), pages 6247-6250, XP004027360 ISSN: 0040-4039 *
NEWHALL, W. F.: "Derivatives of (+)-Limonene. II. 2-Amino-1-p-menthanols." J. ORG. CHEM., vol. 24, 1959, pages 1673-1676, XP002297508 *
SMITH, W. B.: "Ring Opening of Epoxides with Morpholine-Borane" J. ORG. CHEM., vol. 49, 1984, pages 3219-3220, XP002297573 *
STEINER D ET AL: "A facile and efficient method for the kinetic separation of commercially available cis- and trans-limonene epoxide" TETRAHEDRON: ASYMMETRY, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 13, no. 21, 31 October 2002 (2002-10-31), pages 2359-2363, XP004392003 ISSN: 0957-4166 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2123264A1 (en) 2006-04-24 2009-11-25 Allergan, Inc. Heterocyclic derivatives as abnormal cannabidiols agents for lowering intraocular pressure
CN112661656A (zh) * 2020-12-19 2021-04-16 浙江新和成股份有限公司 (1s,4r)-1-甲基-4-(1-甲基乙烯基)-2-环己烯-1-醇的制备方法
CN112661656B (zh) * 2020-12-19 2022-05-20 浙江新和成股份有限公司 (1s,4r)-1-甲基-4-(1-甲基乙烯基)-2-环己烯-1-醇的制备方法
EP4144717A1 (en) * 2021-09-07 2023-03-08 SCI Pharmtech Inc Method for purification of terpenoid amino alcohol derivatives
TWI828123B (zh) * 2021-09-07 2024-01-01 旭富製藥科技股份有限公司 萜類胺基醇衍生物的純化方法

Also Published As

Publication number Publication date
CA2523419C (en) 2012-05-01
CN1777569A (zh) 2006-05-24
CA2523419A1 (en) 2004-11-11
US7323607B2 (en) 2008-01-29
EP1660421A2 (en) 2006-05-31
MXPA05011292A (es) 2006-01-24
US20060084828A1 (en) 2006-04-20
WO2004096740A3 (en) 2005-06-02
JP2006524247A (ja) 2006-10-26
AU2004234350A1 (en) 2004-11-11

Similar Documents

Publication Publication Date Title
HU193161B (en) Process for preparing new n-alkyl-norscopines
JPH09316072A (ja) パロキセチンの製造方法
EP0372635B1 (en) Method of preparing dialkyl and diallyl dicarbonates
CA2523419C (en) Process for preparation of (+)-p-mentha-2,8-diene-1-ol
EP0147472B1 (en) 4-chloro-4-methyl-5-methylene-1,3-dioxolan-2-one
US2996521A (en) Alpha-amino-beta-hydroxycarboxylic acid derivatives
KR100203457B1 (ko) 터르비나핀의 제조방법
JP2006524247A5 (enExample)
JP2006513246A (ja) 水溶性β−ヒドロキシニトリルの製造
JPS6133829B2 (enExample)
JP2867847B2 (ja) 5−メチレン−1,3−ジオキソラン−4−オン類の製造方法
EP0288495B1 (en) Synthesis of n-epoxypropyl lactams
EP0015577B1 (en) Process for producing 1,1,3,3-tetrafluoro-1,3-dihydro-isobenzofuran
JP3626520B2 (ja) 3−置換−3−メチルブタナールの製造方法
JPS5944315B2 (ja) 2−ペンチニルエ−テルの製造法
GB2137193A (en) Chlorosulphonic Acid Esters
KR100461571B1 (ko) 고순도 (s)-1,2,4-부탄트리올의 제조방법
KR100297802B1 (ko) 2-(3-트리플루오로메틸)아닐리노니코틴산2-(n-몰포린)에틸의제조방법.
JPH06345756A (ja) セサモールの製造法
JP2007001978A (ja) エーテルの製造方法
KR100927242B1 (ko) 알릴알렌 유도체와 이의 제조방법
KR100508688B1 (ko) N,n-디글리시딜알킬아민 화합물의 효율적 제조방법
JP2001151784A (ja) 1−アミノ−3−ハロ−2−(トリアルキルシロキシ)プロパンの製造法及び3−(トリアルキルシロキシ)アゼチジンの製造法
JPH11279099A (ja) エーテル化合物の製造方法
JPS5993069A (ja) エポキシコハク酸モノエステルの製造法

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2006084828

Country of ref document: US

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 10549976

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 171459

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: PA/a/2005/011292

Country of ref document: MX

Ref document number: 2006510032

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2726/CHENP/2005

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 2523419

Country of ref document: CA

Ref document number: 20048109761

Country of ref document: CN

Ref document number: 2004234350

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2004234350

Country of ref document: AU

Date of ref document: 20040414

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2004234350

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2004760258

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 10549976

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2004760258

Country of ref document: EP